nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroflumethiazide—Gastric irritation—Hydroxyurea—brain cancer	0.0289	0.0624	CcSEcCtD
Hydroflumethiazide—SLC12A1—ganglion—brain cancer	0.0269	0.0502	CbGeAlD
Hydroflumethiazide—KCNMA1—ganglion—brain cancer	0.0244	0.0455	CbGeAlD
Hydroflumethiazide—Epigastric discomfort—Hydroxyurea—brain cancer	0.0213	0.046	CcSEcCtD
Hydroflumethiazide—KCNMA1—blood vessel—brain cancer	0.0194	0.0361	CbGeAlD
Hydroflumethiazide—KCNMA1—hindbrain—brain cancer	0.0185	0.0345	CbGeAlD
Hydroflumethiazide—CA4—ganglion—brain cancer	0.0145	0.027	CbGeAlD
Hydroflumethiazide—Hyperuricaemia—Hydroxyurea—brain cancer	0.0121	0.0261	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Procarbazine—brain cancer	0.012	0.0259	CcSEcCtD
Hydroflumethiazide—ATP1A1—hindbrain—brain cancer	0.0119	0.0221	CbGeAlD
Hydroflumethiazide—Vascular purpura—Procarbazine—brain cancer	0.0118	0.0254	CcSEcCtD
Hydroflumethiazide—CA14—telencephalon—brain cancer	0.0116	0.0216	CbGeAlD
Hydroflumethiazide—Blood uric acid increased—Hydroxyurea—brain cancer	0.0114	0.0247	CcSEcCtD
Hydroflumethiazide—CA4—hindbrain—brain cancer	0.011	0.0205	CbGeAlD
Hydroflumethiazide—Purpura—Procarbazine—brain cancer	0.0109	0.0236	CcSEcCtD
Hydroflumethiazide—KCNMA1—brainstem—brain cancer	0.0106	0.0198	CbGeAlD
Hydroflumethiazide—SLC12A1—telencephalon—brain cancer	0.0104	0.0194	CbGeAlD
Hydroflumethiazide—CA7—midbrain—brain cancer	0.00998	0.0186	CbGeAlD
Hydroflumethiazide—KCNMA1—telencephalon—brain cancer	0.00941	0.0175	CbGeAlD
Hydroflumethiazide—CA2—hindbrain—brain cancer	0.00911	0.017	CbGeAlD
Hydroflumethiazide—CA14—medulla oblongata—brain cancer	0.00909	0.0169	CbGeAlD
Hydroflumethiazide—CA12—telencephalon—brain cancer	0.00902	0.0168	CbGeAlD
Hydroflumethiazide—Leukopenia—Lomustine—brain cancer	0.00893	0.0193	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Procarbazine—brain cancer	0.00891	0.0192	CcSEcCtD
Hydroflumethiazide—CA14—midbrain—brain cancer	0.00831	0.0155	CbGeAlD
Hydroflumethiazide—Photosensitivity reaction—Procarbazine—brain cancer	0.0083	0.0179	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Temozolomide—brain cancer	0.00822	0.0178	CcSEcCtD
Hydroflumethiazide—CA14—spinal cord—brain cancer	0.00811	0.0151	CbGeAlD
Hydroflumethiazide—Thrombocytopenia—Lomustine—brain cancer	0.00797	0.0172	CcSEcCtD
Hydroflumethiazide—Jaundice—Procarbazine—brain cancer	0.0079	0.0171	CcSEcCtD
Hydroflumethiazide—KCNMA1—gonad—brain cancer	0.00786	0.0146	CbGeAlD
Hydroflumethiazide—Anorexia—Lomustine—brain cancer	0.00776	0.0168	CcSEcCtD
Hydroflumethiazide—CA7—cerebellum—brain cancer	0.00772	0.0144	CbGeAlD
Hydroflumethiazide—CA9—endocrine gland—brain cancer	0.0077	0.0143	CbGeAlD
Hydroflumethiazide—Hyperuricaemia—Etoposide—brain cancer	0.00756	0.0163	CcSEcCtD
Hydroflumethiazide—SLC12A1—spinal cord—brain cancer	0.00728	0.0136	CbGeAlD
Hydroflumethiazide—CA1—telencephalon—brain cancer	0.00715	0.0133	CbGeAlD
Hydroflumethiazide—Blood uric acid increased—Etoposide—brain cancer	0.00714	0.0154	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Temozolomide—brain cancer	0.00711	0.0153	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Lomustine—brain cancer	0.00708	0.0153	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Hydroxyurea—brain cancer	0.0069	0.0149	CcSEcCtD
Hydroflumethiazide—ATP1A1—brainstem—brain cancer	0.00681	0.0127	CbGeAlD
Hydroflumethiazide—CA9—cerebellum—brain cancer	0.00678	0.0126	CbGeAlD
Hydroflumethiazide—KCNMA1—midbrain—brain cancer	0.00676	0.0126	CbGeAlD
Hydroflumethiazide—CA5B—gonad—brain cancer	0.00676	0.0126	CbGeAlD
Hydroflumethiazide—Purpura—Temozolomide—brain cancer	0.0066	0.0142	CcSEcCtD
Hydroflumethiazide—SLC12A1—head—brain cancer	0.00647	0.0121	CbGeAlD
Hydroflumethiazide—CA14—cerebellum—brain cancer	0.00643	0.012	CbGeAlD
Hydroflumethiazide—CA4—brainstem—brain cancer	0.0063	0.0117	CbGeAlD
Hydroflumethiazide—CA7—brain—brain cancer	0.00627	0.0117	CbGeAlD
Hydroflumethiazide—ATP1A1—telencephalon—brain cancer	0.00605	0.0113	CbGeAlD
Hydroflumethiazide—KCNMA1—endocrine gland—brain cancer	0.00594	0.0111	CbGeAlD
Hydroflumethiazide—SLC12A1—central nervous system—brain cancer	0.00591	0.011	CbGeAlD
Hydroflumethiazide—KCNMA1—head—brain cancer	0.00586	0.0109	CbGeAlD
Hydroflumethiazide—CA12—endocrine gland—brain cancer	0.00569	0.0106	CbGeAlD
Hydroflumethiazide—Leukopenia—Procarbazine—brain cancer	0.00567	0.0122	CcSEcCtD
Hydroflumethiazide—CA12—head—brain cancer	0.00562	0.0105	CbGeAlD
Hydroflumethiazide—CA4—telencephalon—brain cancer	0.00559	0.0104	CbGeAlD
Hydroflumethiazide—KCNMA1—central nervous system—brain cancer	0.00535	0.00997	CbGeAlD
Hydroflumethiazide—KCNMA1—cerebellum—brain cancer	0.00523	0.00974	CbGeAlD
Hydroflumethiazide—CA14—brain—brain cancer	0.00522	0.00973	CbGeAlD
Hydroflumethiazide—CA2—brainstem—brain cancer	0.00522	0.00973	CbGeAlD
Hydroflumethiazide—Vomiting—Lomustine—brain cancer	0.00518	0.0112	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Carmustine—brain cancer	0.00513	0.0111	CcSEcCtD
Hydroflumethiazide—CA12—central nervous system—brain cancer	0.00513	0.00956	CbGeAlD
Hydroflumethiazide—CA5B—endocrine gland—brain cancer	0.00511	0.00951	CbGeAlD
Hydroflumethiazide—Thrombocytopenia—Procarbazine—brain cancer	0.00506	0.0109	CcSEcCtD
Hydroflumethiazide—ATP1A1—gonad—brain cancer	0.00505	0.0094	CbGeAlD
Hydroflumethiazide—CA5B—head—brain cancer	0.00504	0.00939	CbGeAlD
Hydroflumethiazide—Photosensitivity reaction—Temozolomide—brain cancer	0.00502	0.0108	CcSEcCtD
Hydroflumethiazide—CA1—spinal cord—brain cancer	0.00501	0.00933	CbGeAlD
Hydroflumethiazide—Hyperglycaemia—Temozolomide—brain cancer	0.00496	0.0107	CcSEcCtD
Hydroflumethiazide—Anorexia—Procarbazine—brain cancer	0.00493	0.0106	CcSEcCtD
Hydroflumethiazide—ATP1A1—pituitary gland—brain cancer	0.00492	0.00917	CbGeAlD
Hydroflumethiazide—Nausea—Lomustine—brain cancer	0.00484	0.0104	CcSEcCtD
Hydroflumethiazide—ATP1A1—medulla oblongata—brain cancer	0.00475	0.00885	CbGeAlD
Hydroflumethiazide—SLC12A1—brain—brain cancer	0.00469	0.00873	CbGeAlD
Hydroflumethiazide—CA2—telencephalon—brain cancer	0.00463	0.00863	CbGeAlD
Hydroflumethiazide—CA5B—central nervous system—brain cancer	0.0046	0.00857	CbGeAlD
Hydroflumethiazide—Cramp muscle—Etoposide—brain cancer	0.00458	0.00989	CcSEcCtD
Hydroflumethiazide—CA4—pituitary gland—brain cancer	0.00455	0.00848	CbGeAlD
Hydroflumethiazide—CA1—endocrine gland—brain cancer	0.00451	0.0084	CbGeAlD
Hydroflumethiazide—Decreased appetite—Procarbazine—brain cancer	0.00449	0.0097	CcSEcCtD
Hydroflumethiazide—CA1—head—brain cancer	0.00445	0.00829	CbGeAlD
Hydroflumethiazide—Constipation—Procarbazine—brain cancer	0.00442	0.00954	CcSEcCtD
Hydroflumethiazide—CA4—medulla oblongata—brain cancer	0.00439	0.00818	CbGeAlD
Hydroflumethiazide—Leukopenia—Hydroxyurea—brain cancer	0.00439	0.00947	CcSEcCtD
Hydroflumethiazide—ATP1A1—midbrain—brain cancer	0.00434	0.00809	CbGeAlD
Hydroflumethiazide—KCNMA1—brain—brain cancer	0.00425	0.00791	CbGeAlD
Hydroflumethiazide—ATP1A1—spinal cord—brain cancer	0.00424	0.00789	CbGeAlD
Hydroflumethiazide—Urticaria—Procarbazine—brain cancer	0.00411	0.00887	CcSEcCtD
Hydroflumethiazide—CA12—brain—brain cancer	0.00407	0.00759	CbGeAlD
Hydroflumethiazide—CA1—central nervous system—brain cancer	0.00406	0.00757	CbGeAlD
Hydroflumethiazide—CA4—midbrain—brain cancer	0.00401	0.00748	CbGeAlD
Hydroflumethiazide—Thrombocytopenia—Hydroxyurea—brain cancer	0.00392	0.00846	CcSEcCtD
Hydroflumethiazide—CA4—spinal cord—brain cancer	0.00392	0.00729	CbGeAlD
Hydroflumethiazide—Jaundice—Etoposide—brain cancer	0.00382	0.00825	CcSEcCtD
Hydroflumethiazide—ATP1A1—endocrine gland—brain cancer	0.00381	0.00711	CbGeAlD
Hydroflumethiazide—Anorexia—Hydroxyurea—brain cancer	0.00381	0.00823	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Procarbazine—brain cancer	0.00381	0.00822	CcSEcCtD
Hydroflumethiazide—CA2—pituitary gland—brain cancer	0.00377	0.00703	CbGeAlD
Hydroflumethiazide—ATP1A1—head—brain cancer	0.00377	0.00701	CbGeAlD
Hydroflumethiazide—Asthenia—Procarbazine—brain cancer	0.00371	0.00801	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Etoposide—brain cancer	0.00366	0.0079	CcSEcCtD
Hydroflumethiazide—CA5B—brain—brain cancer	0.00365	0.00681	CbGeAlD
Hydroflumethiazide—Agitation—Carmustine—brain cancer	0.00364	0.00786	CcSEcCtD
Hydroflumethiazide—CA2—medulla oblongata—brain cancer	0.00364	0.00678	CbGeAlD
Hydroflumethiazide—Leukopenia—Carmustine—brain cancer	0.00355	0.00766	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Procarbazine—brain cancer	0.00354	0.00764	CcSEcCtD
Hydroflumethiazide—CA4—endocrine gland—brain cancer	0.00352	0.00657	CbGeAlD
Hydroflumethiazide—Agitation—Temozolomide—brain cancer	0.00352	0.0076	CcSEcCtD
Hydroflumethiazide—CA4—head—brain cancer	0.00348	0.00648	CbGeAlD
Hydroflumethiazide—Decreased appetite—Hydroxyurea—brain cancer	0.00348	0.00751	CcSEcCtD
Hydroflumethiazide—Vertigo—Temozolomide—brain cancer	0.00344	0.00743	CcSEcCtD
Hydroflumethiazide—ATP1A1—central nervous system—brain cancer	0.00344	0.0064	CbGeAlD
Hydroflumethiazide—Leukopenia—Temozolomide—brain cancer	0.00343	0.0074	CcSEcCtD
Hydroflumethiazide—Constipation—Hydroxyurea—brain cancer	0.00342	0.00739	CcSEcCtD
Hydroflumethiazide—Dizziness—Procarbazine—brain cancer	0.00342	0.00738	CcSEcCtD
Hydroflumethiazide—ATP1A1—cerebellum—brain cancer	0.00336	0.00626	CbGeAlD
Hydroflumethiazide—CA2—midbrain—brain cancer	0.00333	0.0062	CbGeAlD
Hydroflumethiazide—Vomiting—Procarbazine—brain cancer	0.00329	0.0071	CcSEcCtD
Hydroflumethiazide—Rash—Procarbazine—brain cancer	0.00326	0.00704	CcSEcCtD
Hydroflumethiazide—Dermatitis—Procarbazine—brain cancer	0.00326	0.00703	CcSEcCtD
Hydroflumethiazide—CA2—spinal cord—brain cancer	0.00325	0.00605	CbGeAlD
Hydroflumethiazide—Headache—Procarbazine—brain cancer	0.00324	0.00699	CcSEcCtD
Hydroflumethiazide—CA1—brain—brain cancer	0.00323	0.00601	CbGeAlD
Hydroflumethiazide—CA4—central nervous system—brain cancer	0.00318	0.00592	CbGeAlD
Hydroflumethiazide—Thrombocytopenia—Carmustine—brain cancer	0.00317	0.00684	CcSEcCtD
Hydroflumethiazide—CA4—cerebellum—brain cancer	0.0031	0.00578	CbGeAlD
Hydroflumethiazide—Anorexia—Carmustine—brain cancer	0.00308	0.00666	CcSEcCtD
Hydroflumethiazide—Nausea—Procarbazine—brain cancer	0.00307	0.00663	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Temozolomide—brain cancer	0.00306	0.00661	CcSEcCtD
Hydroflumethiazide—Anorexia—Temozolomide—brain cancer	0.00298	0.00643	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Hydroxyurea—brain cancer	0.00295	0.00636	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Etoposide—brain cancer	0.00295	0.00636	CcSEcCtD
Hydroflumethiazide—CA2—endocrine gland—brain cancer	0.00292	0.00544	CbGeAlD
Hydroflumethiazide—CA2—head—brain cancer	0.00289	0.00538	CbGeAlD
Hydroflumethiazide—Asthenia—Hydroxyurea—brain cancer	0.00287	0.0062	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Carmustine—brain cancer	0.00281	0.00607	CcSEcCtD
Hydroflumethiazide—Constipation—Carmustine—brain cancer	0.00277	0.00597	CcSEcCtD
Hydroflumethiazide—Vertigo—Etoposide—brain cancer	0.00275	0.00594	CcSEcCtD
Hydroflumethiazide—Leukopenia—Etoposide—brain cancer	0.00274	0.00592	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Hydroxyurea—brain cancer	0.00274	0.00591	CcSEcCtD
Hydroflumethiazide—ATP1A1—brain—brain cancer	0.00273	0.00508	CbGeAlD
Hydroflumethiazide—Decreased appetite—Temozolomide—brain cancer	0.00272	0.00587	CcSEcCtD
Hydroflumethiazide—Constipation—Temozolomide—brain cancer	0.00267	0.00577	CcSEcCtD
Hydroflumethiazide—Dizziness—Hydroxyurea—brain cancer	0.00265	0.00571	CcSEcCtD
Hydroflumethiazide—CA2—central nervous system—brain cancer	0.00263	0.00491	CbGeAlD
Hydroflumethiazide—CA2—cerebellum—brain cancer	0.00257	0.0048	CbGeAlD
Hydroflumethiazide—Vomiting—Hydroxyurea—brain cancer	0.00254	0.00549	CcSEcCtD
Hydroflumethiazide—Rash—Hydroxyurea—brain cancer	0.00252	0.00545	CcSEcCtD
Hydroflumethiazide—CA4—brain—brain cancer	0.00252	0.0047	CbGeAlD
Hydroflumethiazide—Dermatitis—Hydroxyurea—brain cancer	0.00252	0.00544	CcSEcCtD
Hydroflumethiazide—Headache—Hydroxyurea—brain cancer	0.00251	0.00541	CcSEcCtD
Hydroflumethiazide—Urticaria—Temozolomide—brain cancer	0.00248	0.00536	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Etoposide—brain cancer	0.00245	0.00529	CcSEcCtD
Hydroflumethiazide—Anorexia—Etoposide—brain cancer	0.00238	0.00515	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Carmustine—brain cancer	0.00238	0.00514	CcSEcCtD
Hydroflumethiazide—Nausea—Hydroxyurea—brain cancer	0.00238	0.00513	CcSEcCtD
Hydroflumethiazide—Asthenia—Carmustine—brain cancer	0.00232	0.00501	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Temozolomide—brain cancer	0.0023	0.00497	CcSEcCtD
Hydroflumethiazide—Asthenia—Temozolomide—brain cancer	0.00224	0.00484	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Carmustine—brain cancer	0.00221	0.00478	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Etoposide—brain cancer	0.00217	0.00469	CcSEcCtD
Hydroflumethiazide—Dizziness—Carmustine—brain cancer	0.00214	0.00462	CcSEcCtD
Hydroflumethiazide—Constipation—Etoposide—brain cancer	0.00214	0.00462	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Temozolomide—brain cancer	0.00214	0.00462	CcSEcCtD
Hydroflumethiazide—CA2—brain—brain cancer	0.00209	0.0039	CbGeAlD
Hydroflumethiazide—Dizziness—Temozolomide—brain cancer	0.00207	0.00446	CcSEcCtD
Hydroflumethiazide—Vomiting—Carmustine—brain cancer	0.00206	0.00444	CcSEcCtD
Hydroflumethiazide—Rash—Carmustine—brain cancer	0.00204	0.0044	CcSEcCtD
Hydroflumethiazide—Dermatitis—Carmustine—brain cancer	0.00204	0.0044	CcSEcCtD
Hydroflumethiazide—Headache—Carmustine—brain cancer	0.00203	0.00437	CcSEcCtD
Hydroflumethiazide—Vomiting—Temozolomide—brain cancer	0.00199	0.00429	CcSEcCtD
Hydroflumethiazide—Urticaria—Etoposide—brain cancer	0.00199	0.00429	CcSEcCtD
Hydroflumethiazide—Rash—Temozolomide—brain cancer	0.00197	0.00425	CcSEcCtD
Hydroflumethiazide—Dermatitis—Temozolomide—brain cancer	0.00197	0.00425	CcSEcCtD
Hydroflumethiazide—Headache—Temozolomide—brain cancer	0.00196	0.00423	CcSEcCtD
Hydroflumethiazide—Nausea—Carmustine—brain cancer	0.00192	0.00415	CcSEcCtD
Hydroflumethiazide—Nausea—Temozolomide—brain cancer	0.00186	0.00401	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Etoposide—brain cancer	0.00184	0.00398	CcSEcCtD
Hydroflumethiazide—Asthenia—Etoposide—brain cancer	0.00179	0.00387	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Etoposide—brain cancer	0.00171	0.00369	CcSEcCtD
Hydroflumethiazide—Dizziness—Etoposide—brain cancer	0.00165	0.00357	CcSEcCtD
Hydroflumethiazide—Vomiting—Etoposide—brain cancer	0.00159	0.00343	CcSEcCtD
Hydroflumethiazide—Rash—Etoposide—brain cancer	0.00158	0.0034	CcSEcCtD
Hydroflumethiazide—Dermatitis—Etoposide—brain cancer	0.00158	0.0034	CcSEcCtD
Hydroflumethiazide—Headache—Etoposide—brain cancer	0.00157	0.00338	CcSEcCtD
Hydroflumethiazide—Nausea—Etoposide—brain cancer	0.00149	0.00321	CcSEcCtD
